Compound ID | 167
Synonym(s): Torezolid | TR-700 | TR700 | DA-7157 | Sivextro
Class: Oxazolidinone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Binds to the 50S ribosomal subunit/23S rRNA and inhibits bacterial protein synthesis. |
| Target Pathogen: | Staphylococcus aureus (including MRSA and MSSA); Streptococcus pyogenes; Streptococcus agalactiae; Streptococcus anginosus group; Enterococcus faecalis |
| Description: | Synthetic oxazolidinone antibacterial that inhibits bacterial protein synthesis by binding the 50S ribosomal subunit; approved by the US FDA in 2014 for the treatment of acute bacterial skin and skin structure infections. |
| Institute where first reported: | Dong A Pharmaceutical Co Ltd |
| Year first mentioned: | 2005 |
| Highest development stage: | Approved |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/11234049 |
| Guide to Pharmacology: | tedizolid |
| Citations: |
|
| Patents: |
|